BLX-883 Uses, Dosage, Side Effects and more
BLX-883 is a form of alfa interferon developed by Biolex for the treatment of hepatitis viral C. Alfa interferon is used in the treatment of hepatitis C, hepatitis B, and multiple cancers and its worldwide sales currently exceed $3 billion.
| Trade Name | BLX-883 |
| Generic | BLX-883 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in hepatitis (viral, C).
How BLX-883 works
BLX-883 is the first clinical-stage therapeutic candidate produced in Biolex' GMP facilities using its proprietary Lex System.
